AbCheck utilizes an unique combination of in vitro and in vivo technologies as sources for antibody discovery. We discover antibodies de novo from animals, or use libraries of human antibodies and project-specifically humanized libraries cloned from immunized rabbits to identify distinctive antibody sequences against our clients‘ targets. AbCheck provides two options for the de novo discovery of antibodies – by binding and by function. In a tailored library workflow, AbCheck provides a seamless and sophisticated transition between phage and yeast display selection strategies. We generate antibodies against virtually all targets in scFv, IgG or bi-specific formats. Our scientific expertise and technology platforms that have been refined and advanced over years, deliver a highly specific and effective antibodies.